399 related articles for article (PubMed ID: 17018600)
21. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
[TBL] [Abstract][Full Text] [Related]
22. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F
Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402
[TBL] [Abstract][Full Text] [Related]
23. Microarray studies of factor VIIa-activated cancer cells.
Petersen LC
Thromb Res; 2008; 122 Suppl 1():S11-3. PubMed ID: 18691491
[TBL] [Abstract][Full Text] [Related]
24. Tissue factor on cells.
Rao LV; Pendurthi UR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S27-35. PubMed ID: 9819026
[TBL] [Abstract][Full Text] [Related]
25. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
26. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
27. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
28. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
[TBL] [Abstract][Full Text] [Related]
29. Emerging insights in tissue factor-dependent signaling events.
Versteeg HH; Ruf W
Semin Thromb Hemost; 2006 Feb; 32(1):24-32. PubMed ID: 16479459
[TBL] [Abstract][Full Text] [Related]
30. Relevance of tissue factor in cardiovascular disease.
Jude B; Zawadzki C; Susen S; Corseaux D
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
[TBL] [Abstract][Full Text] [Related]
31. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y
Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262
[TBL] [Abstract][Full Text] [Related]
32. High-level expression of functional recombinant human coagulation factor VII in insect cells.
Masroori N; Halabian R; Mohammadipour M; Roushandeh AM; Rouhbakhsh M; Najafabadi AJ; Fathabad ME; Salimi M; Shokrgozar MA; Roudkenar MH
Biotechnol Lett; 2010 Jun; 32(6):803-9. PubMed ID: 20213530
[TBL] [Abstract][Full Text] [Related]
33. Tissue factor and protease-activated receptor signaling in cancer.
Schaffner F; Ruf W
Semin Thromb Hemost; 2008 Mar; 34(2):147-53. PubMed ID: 18645919
[TBL] [Abstract][Full Text] [Related]
34. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
35. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
[TBL] [Abstract][Full Text] [Related]
36. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.
Chu AJ
Cell Biochem Funct; 2006; 24(2):173-92. PubMed ID: 15617024
[TBL] [Abstract][Full Text] [Related]
37. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
Bajaj SP; Joist JH
Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
[TBL] [Abstract][Full Text] [Related]
38. [Mechanism of cross talk between tissue factor/active coagulation factor VII and epidermal growth factor receptor signalings in colon cancer cells in culture].
Chen HK; Dai Y; Wu T; Wang X; Wan YL; Tang JQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):931-936. PubMed ID: 29263461
[TBL] [Abstract][Full Text] [Related]
39. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
Lwaleed BA; Goyal A; Delves G; Gossai S; Greenfield RS; Cooper AJ
Int J Androl; 2007 Dec; 30(6):543-9. PubMed ID: 17459125
[TBL] [Abstract][Full Text] [Related]
40. Hypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasion.
Heikkinen PT; Nummela M; Jokilehto T; Grenman R; Kähäri VM; Jaakkola PM
Cancer Res; 2010 Jul; 70(14):5984-93. PubMed ID: 20551054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
